RBC Capital Downgrades Endologix (ELGX) to Sector Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
Endologix Reports Results for the Second Quarter 2016
August 2, 2016 4:06 PM EDTIRVINE, Calif., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Endologix, Inc. (NASDAQ: ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three and six months ended June 30, 2016.
John McDermott, Endologix Chairman and Chief Executive Officer, said, We continue to deliver solid revenue growth above expectations and are very pleased with the TriVascular merger integration. Our revenue performance in the second quarter was driven by strong growth with... More



